BabU
New member
EU Watchdog Reviews Pfizer Vaccine Adapted for Omicron As the company makes progress in the development of its adapted vaccine, EMA will receive more data, including data on the immune response to the vaccine, as well as data on its efficacy against Omicron sub-variants, the European Medicines Agency said